Health Care·Health Care Supplies·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.45 | N/A | -5.26% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.45 | N/A | -5.26% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management remains positive about future opportunities. They emphasized their commitment to innovation and market expansion.
Management expressed confidence in long-term growth despite the EPS miss.
They highlighted ongoing investments in product development.
Despite missing EPS expectations, Haemonetics Corp's stock rose by 1.54%, indicating that investors may be optimistic about the company's long-term prospects. The management's focus on innovation and growth could be driving this positive sentiment. However, the lack of revenue data and guidance leaves some uncertainty for investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
EOG RES INC
Oct 29, 2007